Sunshine Biopharma Inc
Research Sunshine Biopharma Inc (SBFM) on Bullrun: market cap USD 721.33K. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerSBFM
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryDrug Manufacturers-Specialty & Generic
- CurrencyUSD
- Market capUSD 721.33K
- Financial periodQ2 2026
- RevenueUSD 9.26M
- Net income-USD 1.56M
- Free cash flow-USD 923.10K
- Gross margin26.2%
Valuation Snapshot
latest market cap is USD 721.33K.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 36.31M | -USD 5.98M | -USD 5.51M | 33.8% | -14.4 | USD 9.12M | USD 812.42K | USD 23.04M |
| FY2024 | USD 34.87M | -USD 5.13M | -USD 14.18M | 30.6% | -7.32 | USD 9.69M | USD 952.48K | USD 23.50M |
| FY2023 | USD 24.09M | -USD 4.51M | -USD 8.86M | 34.6% | -351.36 | USD 16.29M | USD 657.71K | USD 21.21M |
| FY2022 | USD 4.35M | -USD 26.74M | -USD 5.44M | 39.0% | -1.76 | USD 21.83M | USD 765.26K | USD 21.63M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-12 | USD 721.33K | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 6.03M | n/a | n/a | n/a |
| 2024 | 2024-12-31 | USD 7.74M | n/a | n/a | n/a |
| 2023 | 2023-12-29 | USD 6.96M | n/a | n/a | n/a |
| 2022 | 2022-12-30 | USD 14.46M | 0.0 | n/a | n/a |
About Sunshine Biopharma Inc
Sunshine Biopharma, Inc. operates as a pharmaceutical company that engages in the research and development of life-saving medicines in various therapeutic areas, including oncology and antivirals in the United States and Canada. The company is developing SBFM-PL4, a protease inhibitor for the treatment of SARS coronavirus infections; and K1.1 mRNA, a lipid nano-particle for liver cancer. It also offers Essential 9, an amino acids capsules;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Sunshine Biopharma Inc's market cap?
Sunshine Biopharma Inc's market capitalization is USD 721.33K.
What does Sunshine Biopharma Inc do?
Sunshine Biopharma, Inc. operates as a pharmaceutical company that engages in the research and development of life-saving medicines in various therapeutic areas, including oncology and antivirals in the United States and Canada. The company is developing SBFM-PL4, a protease inhibitor for the treatment of SARS coronavirus infections; and K1.1 mRNA, a lipid nano-particle for liver cancer. It also offers Essential 9, an amino acids capsules; Calcium-Vitamin D supplement under the Essential Calcium-Vitamin D brand name; and L-Citrulline and Taurine products.